Skip to main content
. 2018 Apr 4;61(7):1644–1649. doi: 10.1007/s00125-018-4605-3

Table 1.

Randomly selected beta cell autoantibody positive and negative individuals from the Action LADA cohort (n = 1114), grouped according to binding patterns of f-GADA and t-GADA. Data are presented as median (IQR) or n (%)

Beta cell autoantibody positive Beta cell autoantibody negative f-GADA negative, t-GADA negative f-GADA positive, t-GADA negative (restricted) f-GADA positive t-GADA positive f-GADA positive, t-GADA positive
Samples, n 511 603 628 55 478 431 423
Female, n (%)a 264 (51.9) 281 (46.6) 289 (46.0) 24 (43.6) 251 (52.7) 232 (54.1) 227 (53.9)
Male, n (%)a 245 (48.1) 322 (53.4) 339 (54.0) 31 (56.4) 225 (47.3) 197 (45.9) 194 (46.1)
Age (years) 49.3 (40.7–58.2) 50.8 (41.7–58.6) 51.2 (41.9–58.7) 54.2 (43.6–62.5) 49.0 (40.2–57.6) 48.2 (39.8–57.4) 48.2 (39.7–57.2)
Age at onset (years) 47.6 (38.6–56.0) 48.9 (40.3–56.6) 48.9 (40.5–56.7) 52.0 (41.8–59.8) 47.0 (38.4–55.7) 46.6 (38.0–55.5) 46.4 (37.9–55.1)
Duration of disease (years) 2.0 (0.8–3.6) 1.8 (0.5–3.5) 2.0 (0.5–3.5) 1.8 (0.3–3.10) 2.0 (0.7–3.5) 2.0 (0.8–3.5) 2.0 (0.8–3.5)
BMI (kg/m2)b 26.0 (22.9–30.1) 29.5 (26.6–33.8) 29.7 (26.6–34.1) 29.9 (26.7–35.9) 25.6 (22.8–29.4) 24.9 (22.6–28.8) 24.8 (22.6–28.8)
Individuals on insulin, n (%)c 238 of 487 (48.9) 120 of 558 (21.5) 126 of 587 (21.5) 7 of 51 (13.7) 231 of 451 (51.2) 225 of 407 (55.3) 224 of 400 (56.0)

Missing information for asex (n = 2), bBMI (n = 55), cdiabetes treatment (n = 69)